<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">
<Articles><Article><Journal><PublisherName></PublisherName><JournalTitle>International Journal of Preventive Medicine (Int J Prev Med)</JournalTitle><Issn>2008-7802</Issn><Volume>3</Volume><Issue>4</Issue><PubDate PubStatus="epublish"><Year>2012</Year><Month>03</Month><Day>27</Day></PubDate></Journal><title locale="en_US">Children Contacting with Smear Positive Tuberculosis Patients</title><FirstPage>599</FirstPage><LastPage>599</LastPage><Language>EN</Language><AuthorList><Author><affiliation locale="en_US">Wiwanitkit House, Bangkhae, Bangkok, Thailand 10160</affiliation></Author></AuthorList><History><PubDate PubStatus="received"><Year>2012</Year><Month>03</Month><Day>27</Day></PubDate></History><abstract locale="en_US">I read the recent publication on children contacting with smear positive tuberculosis patients with great interest.[1] Aminzadeh &lt;em&gt;et al&lt;/em&gt;. concluded that the &amp;lsquo;Strategy of six months of supervised isonicotinylhydrazine (INH) chemoprophylaxis is successful, particularly in children who are at high risk to progress to the disease, following exposure.[1] I agree with the usefulness and effectiveness of such a practice. However, I am concerned about the possible side effects of chemoprophylaxis on the children. A further cost-benefit weighting study is warranted.</abstract><web_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/view/599</web_url><pdf_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/download/599/437</pdf_url></Article></Articles>
